Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0M0PY
|
||||
Former ID |
DPR000039
|
||||
Drug Name |
DX-890
|
||||
Indication | Acute lung injury; Acute respiratory distress syndrome; Cystic fibrosis [ICD9: 277.0, 518.5, 518.82, 709.2; ICD10:E84, J80, L90.5] | Phase 2 | [522003] | ||
Company |
Dyax Corp.
|
||||
Structure |
Download2D MOL |
||||
CAS Number |
CAS 10024-97-2
|
||||
ChEBI ID |
ChEBI:17045
|
||||
SuperDrug ATC ID |
N01AX13
|
||||
SuperDrug CAS ID |
cas=010024972
|
||||
Target and Pathway | |||||
Target(s) | Leukocyte elastase | Target Info | Inhibitor | [536500] | |
Pathway Interaction Database | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling | ||||
C-MYB transcription factor network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.